SAT421 Near Term Cardiometabolic Outcomes of Testosterone Therapy In Transgender Boys And Men

Disclosure: J. Dey: None. C. O’neill: None. C. Bingham-Tyson: None. M.E. Widlansky: None. S. Cabrera: None. Background: Medical therapy for transgender males may include GnRH agonists and gender affirming testosterone (T) hormone therapy (GAHT). Given the clear sexual dimorphism in cardiometabolic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Justin, O'neill, Cailey, Bingham-Tyson, Clare, Widlansky, Michael E, Cabrera, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555416/
http://dx.doi.org/10.1210/jendso/bvad114.2092

Ejemplares similares

Ejemplares similares